There were no statistically significant differences in these parameters when the patients were reassessed due to the reduced number of tumor cells after therapy (i.e., a reduced SUVmax), as interleukin-6, CRP, and ferritin had also been reduced. The gene discussed is CRP; the disease is neoplasm.